Prognosis of Patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy
- 31 March 1998
- journal article
- Published by Elsevier in American Journal Of Medicine
- Vol. 104 (3), 232-237
- https://doi.org/10.1016/s0002-9343(98)00037-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phase II trial of recombinant interferon alfa‐2 in the treatment of primary systemic amyloidosisAmerican Journal of Hematology, 1993
- Phase II trial of α‐tocopherol (vitamin E) in the treatment of primary systemic amyloidosisAmerican Journal of Hematology, 1990
- Multivariate survival analysis using Cox's regression modelHepatology, 1987
- The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathyMuscle & Nerve, 1983
- The natural history of peripheral neuropathy in primary systemic amyloidosisAnnals of Neurology, 1979
- AMYLOIDOSIS: REVIEW OP 236 CASESMedicine, 1975
- NEUROPATHY, M COMPONENTS, AND AMYLOIDThe Lancet, 1975
- PERIPHERAL NERVE CHANGES IN AMYLOID NEUROPATHYBrain, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- A CASE OF PRIMARY GENERALIZED AMYLOID DISEASE WITH INVOLVEMENT OF THE NERVESBrain, 1938